-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 CYTh8dyCQQ/kI+foiYBCiijizPV5nW6P8k9CylI5w0DovaHuF1NBC+LgreUsaPKU
 P0asD1znoIlNWisCZQjNyw==

<SEC-DOCUMENT>0001104659-07-082752.txt : 20071114
<SEC-HEADER>0001104659-07-082752.hdr.sgml : 20071114
<ACCEPTANCE-DATETIME>20071114084011
ACCESSION NUMBER:		0001104659-07-082752
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20071113
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20071114
DATE AS OF CHANGE:		20071114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			MN
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		071240906

	BUSINESS ADDRESS:	
		STREET 1:		1285 CORPORATE CENTER DR.
		STREET 2:		SUITE 175
		CITY:			EAGAN
		STATE:			MN
		ZIP:			55121
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		1285 CORPORATE CENTER DR.
		STREET 2:		SUITE 175
		CITY:			EAGAN
		STATE:			MN
		ZIP:			55121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a07-29341_18k.htm
<DESCRIPTION>8-K
<TEXT>
<html>

<head>





</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">

<div style="border:none;border-top:double windowtext 6.0pt;padding:0in 0in 0in 0in;">

<p style="border:none;margin:0in 0in .0001pt;padding:0in;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

</div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington,
D.C. 20549</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM 8-K</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT
REPORT</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Pursuant to Section&nbsp;13 or
15(d) of the Securities Exchange Act of 1934</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">&nbsp;</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date
of Report (Date of earliest event reported):<b> November 13,
2007</b></font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">BIO-key International, Inc.</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact
name of registrant as specified in its charter)</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b>  <br> (State or other jurisdiction of<br>
  incorporation)</p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">1-13463</font></b><br> (Commission File Number)</p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
  <td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
  <p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">41-1741861<br>
  </font></b>(I.R.S. Employer
  Identification No.)</p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div align="center">

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="100%" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
  <p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">3349 Highway 138, Building D, Suite B</font></b>  <br>
  <b>Wall, NJ 07719<br>
  </b>(Address of principal
  executive offices)</p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
  <p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
  </td>
 </tr>
 <tr>
  <td width="100%" valign="top" style="padding:0in 0in 0in 0in;width:100.0%;">
  <p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(732)&nbsp;359-1100</font></b><br> (Registrant&#146;s telephone number,
  including area code)</p>
  </td>
 </tr>
</table>

</div>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in 12.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (<i>see</i> General
Instruction A.2 below):</font></p>

<p style="margin:0in 0in 12.0pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</font></p>

<p style="margin:0in 0in 12.0pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)</font></p>

<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))</font></p>

<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt .25in;text-indent:-.25in;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><font size="2" style="font-size:10.0pt;">
Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act
(17 CFR 240.13e-4(c))</font></p>

<div style="border:none;border-bottom:double windowtext 6.0pt;padding:0in 0in 0in 0in;">

<p style="border:none;margin:0in 0in .0001pt;padding:0in;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

</div>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;text-autospace:none;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\keliason\07-29341-1\task2526801\29341-1-ba.htm',USER='keliaso',CD='Nov 14 07:38 2007' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;">

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 2.02.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b>Results of Operations and
Financial Condition.</b></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On
November 13, 2007, BIO-key International, Inc. (the &#147;Company&#148;) issued a press
release announcing its financial results for its third quarter ended September
30, 2007. &nbsp;A copy of such press release of the Registrant is attached as
Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by
reference in its entirety.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The
information, including the exhibit attached hereto, in this Current Report on
Form 8-K shall not be deemed &#147;filed&#148; for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or otherwise subject to
the liabilities of that Section, nor shall it be deemed incorporated by
reference in any filing under the Securities Act of 1933 or the Exchange Act,
except as otherwise expressly stated in such filing.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 9.01.</font></b><b><font size="1" style="font-size:8.5pt;font-weight:bold;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font></b><b>Financial Statements, Pro Forma
Financial Information and Exhibits.</b></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; Exhibits</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">99.1&#160;&#160;&#160;&#160;&#160; Press Release, dated November 13, 2007,
issued by </font>the Company.</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>

<div style="margin:0in 0in .0001pt;text-autospace:none;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\keliason\07-29341-1\task2526801\29341-1-ba.htm',USER='keliaso',CD='Nov 14 07:38 2007' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;text-autospace:none;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;text-autospace:none;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.54%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="35%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:35.46%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-KEY INTERNATIONAL,
  INC.</font></p>
  </td>
 </tr>
 <tr>
  <td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.54%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date: November 13, 2007</font></p>
  </td>
  <td width="35%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:35.46%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.54%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.62%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>
  </td>
  <td width="21%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:21.64%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ Francis J. Cusick</font></p>
  </td>
  <td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.2%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.54%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.62%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="21%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:21.64%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Francis J. Cusick</font></p>
  </td>
  <td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.2%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.54%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="3%" valign="top" style="padding:0in 0in 0in 0in;width:3.62%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="21%" valign="top" style="padding:0in 0in 0in 0in;width:21.64%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Chief Financial Officer</font></p>
  </td>
  <td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.2%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt 3.8in;text-autospace:none;text-indent:-.3in;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;text-autospace:none;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\keliason\07-29341-1\task2526801\29341-1-ba.htm',USER='keliaso',CD='Nov 14 07:38 2007' -->


<br clear="all" style="page-break-before:always;">


<div style="font-family:Times New Roman;"><p style="color:black;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" color="black" face="Times New Roman" style="color:windowtext;font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p><p style="color:black;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" color="black" face="Times New Roman" style="color:windowtext;font-size:10.0pt;font-weight:bold;">EXHIBIT INDEX</font></b></p><p style="color:black;margin:0in 0in .0001pt;text-align:center;"><font size="2" color="black" face="Times New Roman" style="color:windowtext;font-size:10.0pt;">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="8%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:8.34%;"><p style="color:black;margin:0in 0in .0001pt;"><b><font size="1" color="black" face="Times New Roman" style="color:windowtext;font-size:8.0pt;font-weight:bold;">Exhibit No.</font></b></p></td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.66%;"><p style="color:black;margin:0in 0in .0001pt;"><b><font size="1" color="black" face="Times New Roman" style="color:windowtext;font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p></td>
  <td width="89%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:89.0%;"><p style="color:black;margin:0in 0in .0001pt;text-align:center;"><b><font size="1" color="black" face="Times New Roman" style="color:windowtext;font-size:8.0pt;font-weight:bold;">Description</font></b></p></td>
 </tr>
 <tr>
  <td width="8%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:8.34%;"><p style="color:black;margin:0in 0in .0001pt;"><font size="2" color="black" face="Times New Roman" style="color:windowtext;font-size:10.0pt;">&nbsp;</font></p></td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.66%;"><p style="color:black;margin:0in 0in .0001pt;"><font size="2" color="black" face="Times New Roman" style="color:windowtext;font-size:10.0pt;">&nbsp;</font></p></td>
  <td width="89%" valign="top" style="border:none;padding:0in 0in 0in 0in;width:89.0%;"><p style="color:black;margin:0in 0in .0001pt;"><font size="2" color="black" face="Times New Roman" style="color:windowtext;font-size:10.0pt;">&nbsp;</font></p></td>
 </tr>
 <tr>
  <td width="8%" valign="top" style="padding:0in 0in 0in 0in;width:8.34%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>
  </td>
  <td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.66%;">
  <p style="margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="89%" valign="top" style="padding:0in 0in 0in 0in;width:89.0%;">
  <p style="font-size:10.0pt;margin:0in 0in .0001pt;text-autospace:none;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Press
  Release, dated </font>November 13, 2007, issued by the Company.</p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt 138.0pt;text-autospace:none;text-indent:-138.0pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;text-autospace:none;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\keliason\07-29341-1\task2526801\29341-1-ba.htm',USER='keliaso',CD='Nov 14 07:38 2007' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a07-29341_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>

<head>





</head>

<body lang="EN-US">

<div style="font-family:Times New Roman;">

<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;99.1</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;width:100.0%;">
 <tr>
  <td width="46%" rowspan="9" valign="top" style="padding:0in 0in 0in 0in;width:46.3%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="192" height="144" src="g293411mmi001.jpg"></font></p>
  </td>
  <td width="53%" colspan="3" valign="top" style="padding:0in 0in 0in 0in;width:53.7%;">
  <p style="margin:0in 0in .0001pt 50.0pt;text-indent:-10.0pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">NEWS RELEASE</font></i></b></p>
  </td>
 </tr>
 <tr>
  <td width="20%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:20.34%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.36%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.74%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Company Contact:</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.6%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.36%;">
  <p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key
  International,&nbsp;Inc.</font></u></p>
  </td>
 </tr>
 <tr>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.74%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.6%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.36%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Bud
  Yanak</font></p>
  </td>
 </tr>
 <tr>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.74%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.6%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.36%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">732-359-1113</font></p>
  </td>
 </tr>
 <tr>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.74%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.6%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
  <td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.36%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
  </td>
 </tr>
 <tr>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.74%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investor Contact:</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.6%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.36%;">
  <p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">DRG&amp;E</font></u></p>
  </td>
 </tr>
 <tr>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.74%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.6%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.36%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gus Okwu, Managing Director</font></p>
  </td>
 </tr>
 <tr>
  <td width="15%" valign="top" style="padding:0in 0in 0in 0in;width:15.74%;">
  <p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.6%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
  </td>
  <td width="33%" valign="top" style="padding:0in 0in 0in 0in;width:33.36%;">
  <p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">404-892-8178</font></p>
  </td>
 </tr>
</table>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">BIO-key
Reports Third Quarter 2007 Results</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><i><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Strong
Future Outlook For Biometrics Revenue and Profit Growth</font></u></i></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Wall, NJ, November&nbsp;13, 2007</font></b> &#150; BIO-key International,&nbsp;Inc. (OTC
Bulletin Board: BKYI), a leader in wireless public safety and finger-based
biometric identification solutions, today announced its financial results for
the third quarter ended September&nbsp;30, 2007.&#160; </p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total revenue from continuing operations for
the three months ended September&nbsp;30, 2007 was $2.2 million representing a
27% decrease from the $3.0 million reported in the financial statements for the
corresponding period in 2006.&#160; Third
quarter 2007 revenue from continuing operations was impacted primarily by
delays in specific follow-on orders from several of the Company&#146;s Law
Enforcement customers.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key&#146;s gross margin for the third quarter
of 2007 was 79% consistent with the corresponding period in 2006. Operating
expenses from continuing operations for the third quarter of 2007 decreased 14%
to $3.2 million from $3.7 million reported for the third quarter of 2006.
BIO-key&#146;s loss from continuing operations for the third quarter of 2007
improved by $5.7 million to ($1.2 million) from ($6.9 million) for the
corresponding period in 2006.&#160; </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">Net loss was ($1.2 million) for the third
quarter ended September&nbsp;30, 2007 compared to a net loss of ($6.2 million)
for the corresponding period in 2006. </font>The net loss amount in the
2006 period included $5.5&nbsp;million from the extinguishment of convertible
debt. The third quarter 2007 net loss
per share was ($0.03) compared to a net loss per share of ($0.13) for the corresponding
period in 2006. </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\skannan\07-29341-1\task2525620\29341-1-mm.htm',USER='105062',CD='Nov 14 09:51 2007' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;We saw significant improvement in the
performance of our Biometrics business during the third quarter highlighted by
our partnership with Tiger IT to provide a biometric solution for Bangladesh&#146;s
upcoming general election,&#148; said Michael DePasquale, BIO-key&#146;s Chief Executive
Officer.&#160; &#147;This contract represents the
largest biometric registration ever - covering 100 million people - and will
require significant technical capabilities.&#160;
Consequently, we are quite proud to be participating in this
project.&#160; We believe this quarter
represented an inflection point in the growth of our Biometrics group and we
anticipate continued revenue growth to be achieved in the coming quarters.&#160; Given the high gross margin of our biometric
business, small increments of revenue growth have a high leverage impact on
profitability.&#148;&#160;&#160; </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#147;During the third quarter of 2007, we also
continued to maintain our focus on our Law Enforcement business where our
installed base now exceeds more than 750 customers. Our introduction of new
applications - such as MobileCop&#174; Navigator - geared towards enhancing law
enforcement agencies&#146; productivity and efficiency has dramatically increased
our add-on business.&#160; Additional
commitments for new applications in the third quarter of 2007 were received
from police departments in Anchorage, Alaska and Littleton, Colorado.&#148;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">DePasquale concluded, &#147;As a result of our
strengthening biometric forecast, our new law enforcement product applications
releases, strong maintenance service revenues and continued cost controls, I am
increasingly optimistic that we are on a path for revenue growth in the fourth
quarter.&#148; </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total revenue from continuing operations for the nine months ended September&nbsp;30, 2007 was $7.3
million representing a 13% decrease from $8.4 million reported for the
corresponding period in 2006.&nbsp; BIO-key&#146;s
gross margin for the nine months ended September&nbsp;30, 2007 increased to 81% from 77% for the
corresponding period in 2006.&nbsp; Operating expenses from continuing operations
for the nine months ended September&nbsp;30, 2007 decreased 8% to $10.6 million
from $11.5 million reported for the corresponding period in 2006.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><font style="font-size:10.0pt;">BIO-key&#146;s loss from continuing operations for
the nine months ended </font>September&nbsp;30, 2007 improved by $7.2 million to ($5.0 million) from ($12.2 million)
for the corresponding period in 2006.&#160; </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\skannan\07-29341-1\task2525620\29341-1-mm.htm',USER='105062',CD='Nov 14 09:51 2007' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net loss was ($0.4 million) for the nine months ended September&nbsp;30,
2007 compared to a net loss of ($11.1 million) for the corresponding period in
2006. The net loss amount in the 2006 period included $7.8&nbsp;million from
the extinguishment of convertible debt compared to a similar item of $0.4
million for the nine months ended September&nbsp;30, 2007.&#160; During
the first nine months of 2007, BIO-key gained $4.1 million in profit from the
sale of its Fire/EMS services division to ZOLL Data Systems in May&nbsp;2007.&#160; Net loss per share for the nine months
ended September&nbsp;30, 2007 was ($0.03) compared to a net loss per share of
($0.24) for the first nine months of 2006.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Liquidity and Capital Resources</font></u></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Consolidated cash and cash equivalents at September&nbsp;30,
2007 was $0.9 million.&#160; In addition, the
Company held approximately $0.2 million in restricted cash at the conclusion of
the third quarter of 2007.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">Conference Call Details </font></u></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key has scheduled a call for Wednesday, November&nbsp;14<sup>th</sup>
at 8:30&nbsp;a.m. Eastern Time to discuss third quarter 2007 financial
results.&#160; Dialing 303-262-2142 and asking
for the BIO-key call at least 10 minutes prior to the start time can access the
conference call live.&#160; The conference
call will also be broadcast live over the Internet by logging onto
www.bio-key.com.&#160; A telephonic replay of
the conference call will be available through November&nbsp;21, 2007 and may be
accessed by dialing 303-590-3000 and using the pass code 11102027#.&#160; Additionally, an archive of the webcast will
be available shortly after completion of the call on the Company&#146;s website (www.bio-key.com)
for a period of three months. </font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About BIO-key</font></b></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BIO-key International,&nbsp;Inc.,
headquartered in Wall, New Jersey, develops and delivers advanced
identification solutions and information services to law enforcement
departments, public safety agencies, government and private sector
customers.&#160; BIO-key&#146;s mobile wireless
technology provides first responders with critical, reliable, real-time data
and images from local, state and national databases.&#160; BIO-key&#146;s high performance, scalable,
cost-effective and easy-to-deploy biometric finger identification technology
accurately identifies and authenticates users of wireless and enterprise data
to improve security, convenience and privacy and to reduce identity</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\skannan\07-29341-1\task2525620\29341-1-mm.htm',USER='105062',CD='Nov 14 09:51 2007' -->


<br clear="all" style="page-break-before:always;">


<div>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">theft.&#160;
Over 750 police departments in North America use BIO-key solutions,
making BIO-key the leading supplier of mobile and wireless solutions for law
enforcement.&#160; (http://www.bio-key.com)</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This
news release contains forward-looking statements that are subject to certain
risks and uncertainties that may cause actual results to differ materially from
those projected on the basis of these statements.&nbsp; The words &#147;estimate,&#148; &#147;project,&#148;
&#147;intends,&#148; &#147;expects,&#148; &#147;believes&#148; and similar expressions are intended to
identify forward-looking statements.&nbsp; Such forward-looking statements are
made based on management&#146;s beliefs, as well as assumptions made by, and
information currently available to, management pursuant to the &#147;safe-harbor&#148;
provisions of the Private Securities Litigation Reform Act of 1995.&nbsp; For a
more complete description of these and other risk factors that may affect the
future performance of BIO-key International, see &#147;Risk Factors&#148; in the Company&#146;s
Annual Report on Form&nbsp;10-KSB and its other filings with the Securities and
Exchange Commission.&nbsp; Readers are cautioned not to place undue reliance on
these forward-looking statements, which speak only as of the date made.&nbsp;
The Company also undertakes no obligation to disclose any revision to these
forward-looking statements to reflect events or circumstances after the date
made or to reflect the occurrence of unanticipated events.</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"># # #</font></p>

<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman">&nbsp;</font></p>

<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade color="#010101" align="left"></div>

</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\skannan\07-29341-1\task2525620\29341-1-mm.htm',USER='105062',CD='Nov 14 09:51 2007' -->


</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g293411mmi001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g293411mmi001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`"0`,`#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V7-&:**`#
M-&:*0D`$G@"@!<T9KD-?^(^DZ2S06A^WW*\;8CA%/NW^&:\]U?QUK^L%E>[-
MK"?^65O\HQ[GJ:PGB(1TW.^AE]:KK:R\SV+4->TG2A_IVH6\!_NLXW?EUKG;
MOXH^'K<D0?:;HC_GG'@?FV*\=)R2S')/4D\UHZ=X?UC5L?8=.GF4_P`>W"_F
M>*YGB9R^%'I1RNA35ZLOT.[F^+L7_+#1I#[R3`?R!J#_`(6[<?\`0&C_`._Y
M_P`*S[/X5Z[.`;F>UM0>Q8N?TX_6M:'X0IC]_K3Y](X`/YFFGB&2UEL-'K]X
MR/XO/G][HHQ_L3_XBM&U^+.CR$"YLKN#W`5Q^AJ$?"/3\<ZK=D_[BU!-\(8\
M?N-:<'TD@!_D:I?6$9/^S9=U]YU5AXU\.ZD0L&IQ*Y_@E_=G]:W%=74,I#*>
MA!R#7DEY\*=:A!-O<VER/[I)0_KQ68L/C#P@^]$O+6-3SC]Y$?J.15^VG'XX
MF;P5"I_!J+T?]?H>WYHS7G6@_%2&4K#K<`A)X^T0C*_BO4?AFN_M;J"]MTN+
M:9)HG&5=&R#6\*D9[,X*V'J47::)LT9HHJS`,T9HHH`,T9HHH`,T44"@`HHK
M+\0:]:>'M,>]NVR>D<8/S2-Z"DVDKLJ,7)J,=R76-:L-#L6N[^81H.%'5G/H
M!W->1>)O'6I>(&:"(M:6/:%&^9Q_M'O].E9.MZY?:_J#7E[)D](XQ]V-?051
MBBDGE2*)&DD<[511DL?05YU6NYNT=CZ3"8"%%<]367X(9P!Z"NE\.^!=6\0!
M9MOV2T/_`"WE'WA_LKW_`)5V'A+X<P62QWVMHL]S]Y;<\I']?[Q_2N]``&!P
M!T%72PU]9F&*S2SY:/W_`.1S6B^`M"T8*_V;[7<#_EK<?-S[#H*Z4`*````.
M@%+17;&*BK)'ASJ3J.\W<****H@**@N[RVL8#/=W$<$2]7D8**Y/4/BCH-HQ
M2V$]ZP[QKM7\S42G&.[-:=&I5^"-SLZ3J,=J\X_X6Q-.W^B:!)*/^NI8_HM6
M(_B=<Q\WGAJ\C7NR$_U45'MX=SH>`Q"WC^*-W6_`NAZT&=K86UP?^6UOA3GW
M'0UQ,FE^)_AY<M=V3_:]/)S)M!*$?[2_PGW%=GI?Q!\/:HXB%V;68\>7<C9S
M]>GZUTGRR+V96'U!%)PA/WHO7R*C7K4/<JJZ[/\`0Q_#?BBP\2V?G6K;)4'[
MV!C\R'^H]ZVJX/Q#X-N-,O/[?\+?N+J(EI+9/NN.^T?^R]^U=%X8\16_B33!
M<QCRYD.V>$GF-O\`#TJH2=^66YE6I1Y?:4OA_%>IM4445J<H4444`%`HH%`$
M5S<16EM)<3N(XHE+NQZ`"O"O%'B*?Q)J[W3Y6!,K!$?X%]?J>IKMOBGKQBMX
M=$@?YIAYD^/[H/"_B>?PKS"O/Q-2[Y$?0Y7AE&/MI;O84`D@`$D\`#O7K_@3
MP8FBVZZC?Q@ZA*N0#_RP4]A[^OY5S/PS\-KJ&H-J]U'N@M&Q$".&D]?P_F:]
M&O?$>AZ:=M[K%E;L.JR3J#^6:O#4OMLRS/%N_L8/U_R-+%+619^+?#FH2B&T
MURPFD/`1;A<G\,UKYQUKM/#"BJ1UG2@<'4[//_7=?\:GM[RUNPQM;F&<+][R
MI`V/RH`FKE?&/C6#PW']F@59]0D7*QD_+&/[S?X5U)KR'6O#=M_PE,]QK'B7
M38;268R/(]RHEVY^[M]<<>E957-+W#KPD:,IWK.R7XE*PTGQ#X^OS<3SLT2M
MAIY?]7'[*OK["O0M'^'F@Z6JM-;_`&Z<=9+CD9]EZ"M70[_09K..UT2]LYH8
MEPJ6\JM@?0&M6IA1C'5ZLNOCJE3W8>['LAD4$4"!(8DC4=%10!^E/HHK<X3.
MU'P_I&K1E+[3H)L_Q%`&'XCFL)='U7PF?.T:674-.',FGS-ET'K&W]#74W-U
M;V<#3W4\<$2_>DD<*H_$TL$\-U`D]O*DL4@W)(C!E8>H(J'!/7J:QK2BN5ZK
ML0:?J%MJEE'>6DF^*0<'&"#W!'8CTKE=?L7\+ZROBG3D/V=R$U*!!PRD_?`]
M1_GO6TUL-(UP7,`VVNH/LN$'19?X7'U^Z??%:\T,=Q`\,R!XY%*LIZ$'J*37
M,K/=%1FJ<KKX7^0L,J3PI-$X>.10RL.A!Z&GUSOA+S+!;S0)F+-ILN(6/5H6
MY0_AR/PKHJJ+NKF=2/+)H****H@*!10*`/GG5]1EU75[J^E))FE9@#_"N>!^
M55%1I'5$4LS$!0.Y/2O5=;^%UG?W;W6GWC6;2,6>-DWIDG/'0CZ58\,_#FTT
M6\6^O+G[9<1G,8V;40^N.YKS?J]1RU/IEF6'C2]W?L<S\1M#UG1/AY9+I>H?
M9K.R4?;HD8H\SL1SD=1DGBO./AYX1B\:^(WL+FZ>"&.%II&0`LV"!@9^M>W?
M%L?\6VU/_MG_`.C%KRKX,ZE9:/XDU"_U&Y2VMHK!M\CG@9=`*]%*RLCYN4G)
MN3W9H^/_`(16WAK09-9TF]GFCMR/.BGP2%)QD$`="1Q6A\'O%=WK(O/"6K32
M7$#VS&!V8[U7HR;NN,'(],4_XE_%+1-5\-SZ)HDKW4ET0LDVPJB*""<9Y).*
M;\$O!]];7DOB2^A>"%H3%:JXP9-Q!+8],#`]<TR3@/B%X;L_"GBV?2K&25X$
M1'4RD%AN&<9%>P_"GPMIF@^&(?$*S2^??VH>=I'PB*"3P/;U->:_&G_DHUS_
M`-<(O_0:[/6=4DTO]GVP$3;7NX([?(]&)+?H"/QH`Y#QS\2=6\7:H=,T>2:#
M3C)Y<44)(>X.<`MCGGLM='HGP&\^Q2;7-5DAN'&3#;H#L]BQZGZ"N:^"^F)J
M'CV.>5`RV4#SC/\`>X4?^A9_"OHR@#YX\:?"[5/!,(UG3+Z2ZM(F&Z5`8Y8#
MV)P>F>XKL_A1\2KC79?[!UN7S+U4+6]P>LP'56_V@.<]^:]+U"RBU+3KFQG4
M-%<1-&X/H1BOD_3[J?P]XE@N8V*S6-T#D?[+8/Y\T`?7-%-C<21K(O1@"/QI
MU`'SS\9=,U73O$:37VK27MO>EY+>)B0(%!^[CIWZBO6?A82?AOH^?^>;_P#H
M;5Y]^T!_R$=%_P"N,O\`-:Z#PSXVTKP9\,/#\NIK<,+E9%001[NCG.<D`=:`
M/1[RV%W;-"3MS@@^A!R#^8J>N%T3XN^'->U>WTNTAOUGN6VH7A&W/OACBM[Q
M/XPT7PE:+/JMSM:3/EPH-TDGT']3Q0`^YB^S^*K*[7@74#V\GN1\Z_R:MFO)
MI?CCX>NKNW\W2]11(9=ZNI0GH1R,^A-=%J'Q<\*Z?8VEXL]Q=QW8.WR(\E",
M9#`D8//2DE8J3ND=O17`:=\9O#&IZE;V$,.H+)<2+&A:$8!)P,X8FM#Q1\3-
M"\):H--U&.\><QB3]S$"H!Z<DBF2=?0*X_1?B;H6O6ES/91W8-L5#))$%+9!
M/!SC@*2?2NATK5X=51S&C1NGWD;!XR1D$=1D$?4&@"_1110!QOQ:_P"2;:I_
MVS_]&+7DWP>T:PU_7=2TW4H!/;2V)W(21R'0@@CH0:].^,>IV5KX$N[&:YC2
MYN]GDQ$_,^'4G`]`*\[^!4\<7C6XC>15:6R94!.-QW*<#\*`.B\;?!K2+30;
MG4=!:>&>TC,K0R/O610,D#/(.*P/A)X[U"QU^VT"]N'GT^[/EQ+(V3"_\.TG
ML>F/>O7?'.O6>@>$[^>[E57D@>*&,GF1V!``'XU\_?#33)]4\?:4D*%E@F$\
MC#^%5YR?T'XT`:GQH_Y*+<_]<(O_`$&ND\5P/+\`="D49$+0LWT.X?S(KFOC
M1_R46Y_ZX1?^@UZMX?T6+Q%\&[+292%%S8!58_PMG*G\"!0!YU\!YTC\8WD+
M'#2V3;?P937OU?*VB7]_X!\;17%U`Z3V,Q2>$\%E/#`?4'(/TKZ8T;7]+U^Q
M2\TR]BN(G&?E8;E]F'4&@#0)"@DG`')-?(6HM]MUVZ>+D3W+E,=\L<?SKZ`^
M)GQ`L/#^AW.GV=U'-JES&8TCC8$P@\%FQTXZ#UKRWX3^$9?$7BF*]FB)T_3W
M$LK$<,XY5/SY/L*`/2M>^+6F^$=4.ASZ;=7$MK%&)'1E`W%0<<_6LS_A?^E?
M]`.\_P"_JUWVI^#?#>LWK7NI:/;7-PP`:1UY('3-5/\`A6_@W_H7K/\`[Y/^
M-`'E'QDU>'7K;PUJMNCI%=6LDBJ_5<D<&LF3Q7-K7A+0O`VG[(59@ES--@`N
M9"5`/91D$G_)W_CM:V]C<Z#:6L*0P0VTBQQH,!0"N`*YO5?`TD7P_P!*\5V"
MNZ2(1>)G.P[R`X]N`#Z4`>\^$O!^F>$=)BM+2)&F`S-<LHWR-W.>P]!7S_JE
MW<^._B2$FE;;=WHMXQG_`%<6[``_#GZUZM\)O'W_``D6G#1-3ESJ5JGR.QYG
MC'?_`'AW_/UKQV]M'\,^.YK:],L*VUV0[Q\,(R?O+[[3D4`>D_$S6O!6F>&)
M/#&FVEM/>IM6/[.@_P!&(/)9_P"][=>>:I?"[P'J&H:/JW]L6K0:=J-L(X%E
M7YC)GB10>1CU[YKK_!OPT\*:+;QZNLZ:N[#S([N;'EJ.Q"]!]3^E;ND^/-`U
MOQ%/H6G7+7%Q`A<R*N8VQ@$!N^,B@#P[X?W[>#?B0EKJ4:J#*UG.7'W"3@,#
MVY`Y]#7;_&Z]^W7&C^&;.-)+RYE$A^4%@"=J#/49))_"L3XX^&_L&NV^OP)M
MBOALE([2J.#^*_R-2?"Z*]\8^.Y?$NKL)?[-@4!B,#?MVK^@)^M`'J5OX/L[
M7PS::-;;8?LR`>8$SYAVX;<.^[)K0T?1QI:N6D5W8!55%VI&@)(51DG&6/4U
MS6I_%'2+*[:WMK>>]"'#21D*I/L3UK9\-^+]-\3>8EKYD4\8W/#*,,!ZC'!%
M9JK!NR9T2PU:$.>478WJ***T.<YGQCX#TGQK!$+\RPSP`B*>(_,H/4$'@BO.
M;GX!W\4V_3_$$)`.5,L+(P_$$U[96;XCD>+PSJDL3LCI9RLK*<%2$."#0!Y/
M#\"=5NIU?5?$<;*.I1&D;'MN(KT3P]X$TGPOH]Q8:698YKJ,I+>D@S$XP"#V
MQG(`KAM0U7Q#%IO@>YTJYFFNAI\ES-"TC'[4$1&96_O$C.,UO>%[V'QKJ/B;
M9J%V+"X^RM"89V1H<QY(4C[IR,'%`'/S_`62YF::;Q1)*['EY+8LQ^I+UU_@
M/P#+X*-QNUN>_CF4*L++MCCP<Y`R>:S/A]I!DOM8O9M4U2=].U*>UA2:\=TV
M`8&Y3P3SUKG_``;%=ZG;V5S=6GBNY=[DAKN+4,6^!(1G:6S@8YX[&@#O_%O@
M#0_&,0:^B:*Z082ZAX<#T/8CV->;S_`7589V.GZ_;E#WDC9&Q^&:T/%.HQ0>
M-]?;4Y?$365I#`R?V7.R)!E>2_(`R<<_6K&K/XI3X=^&T.I.FK7.H(L<PFR6
M5MY0.R\-QMSVH`J:1\`XDG636=9,T8.3%;1[=W_`C_A7JNE:38:)I\=AIMLE
MM;1#Y40=_4GN?<UQ'A3Q1+XC\=(Y>2$IHY6ZLRQQ#<++M;*^OOZ&L*U\<D_$
M!=8;6XVTZYOFTX6'G?<C``6;;GC+@\^E`'L%%>;>)?#RKX[T6TCU?6(X=6DN
M'N$2_=0-J[@%'\(R>E79KNXTCX@O:Q7%Q-;V?AUI%ADE+;V5^&/JQ`Z]:`,K
MQ)\'+GQ'K=QJ,_B><K*Y:..6'?Y2G^$?,.!]*W?!7P^;PK9WME=ZO)J=G=)L
M^S21[8T'.<`D]<USL.GW]S\/7\;/XDU)=7,#7BLMP1`N"?W?E]-N!BCQ#XDU
MV/7_``_K%AYC(FCB^O+)6.V6/(WX7U`;(^E`$4GP)6'4VN]+\1S6:ART($)+
MQCT#!A^==/XF^&6F>*-.M4O+F8:C;0K$-0`!>7`_C'1O7^M5O"WBB`V/BS79
M+Q[BPM[QI82SD@1^6I"KZ<GIZUD_#3Q-._B!]/O]9347U:V%\BK-O^S2Y.Z+
MKQ\N#CVH`R$^!.K+FW/B:-;4GE5B?G_@.<5Z)X-\!Z1X+MG%D&FNI1B6YEQN
M8>@]![5#X%N[J[N?$@N;B680ZQ+'&'8G8H`PH]![5U9.`2!DT`>:?'#6K&U\
M*1Z1*BRW=[(KQ#O&JGE_Z?B:S;&V/@SX106_^KO]9;S).S!6&?T3`_&LBX\$
M^+_%WQ`&H^(M-:UL?.!D=I%*1PJ<A5Y]/YDT[QIKXU[7&>`_Z';#RK<#I@=6
M_'^6*PKSY8>IWX"A[6LF]EJ<_7<?"B!W\27,X!V1VA5C[EEP/T/Y5P_2O:?A
M[H;:/X<229-MQ>'SG!'('\(_+G\:XL/'FFGV/;S*JH4&NKT.JHHHKU#Y4*@O
MK./4+"XLIBPBN(FB?:<'##!Q^=3T4`8=KX2TZSFT:6)I]VBP-!;9<8*LH4[N
M.3@4[0_"NF>'+S4+G34>,ZC*)98RWRJ1G[H[#DUM4F,T`<SX2?1%GU>WTR2X
M$\EX\]W%<##J[<$@?W>*KV/PZL]-1(K+7M=@A1]ZPQWN$R3D\8Z$U'XP\/WD
M5VGB70"4U&W'[V-1_KD^G<X[=Q6CX5\867B6W"@B"]0?O;=CS]5]1_*LE/7E
MEN=,Z*</:4]5U\BMJRZ-X=U:^U2_M;R6/5XTBNI`GF0HJ@J`0.1D&FZ1X;\.
MW6C:=::=J4MW::?=B[M@)PQC89PO3.WD\&NK=%D0HZAE88*D9!KE=2^'6BWD
MIN+,S:9<'G?:MM&?]W_#%5+F6JU(@J4E:5T^^_X%W_A#-*37-0UF`S6]WJ-N
M;>=HF`&#C+`8X;@<U%)X!\.R>&QH/V)5@6,()E51-P<[M^.N:Q)/!/BVW^6R
M\72L@Z"1G!_F:J2^!/&%Y\MWXD#+WS-(?TXJ'4E_*;K#TG_R]7W,WM>F\-Z9
M>Z7J.I:D[7>DHZP(L@9Y-R[3N4=3@>U84?C3P[=>*5UB+3]4FOWMOLBQ*JLK
M)NW?=SUS4EC\)+=7#ZAJDDOJL*;<_B<FNRTCP[I6A1[=/LTB8C!D/+M]6/-)
M>UD^R*DL)3C97D_N1SD'PWT>Y@4-)JMKI\K^<^D&ZQ`&)S@J.V>P.*Z-M`L6
MUR#5]K":"U:U1`1Y?ED@XQCVK3HK<X#E(OASH4&C7FD0FYCLKVZ%S+$L@QD$
M'8./N\#BM"\\(Z/=7EA>1VRVD]A-YL3VJK&3Q@JV!R".U;=%`'*-\/K,7UW=
MVNM:U9F\G:>6.VN]B%SU.,5U*C:H7).!C)ZFAW6-"[L%51DDG``KS;QC\1@Z
MR:=H4G7Y9+L?R3_'\JB=2,%=F]##SKRY8(?\1/&2A)-"TV7+'Y;J53T']P>_
MK^5>:4O4Y/7UK:\,>&+OQ+?^5$#';1D>=.1PH]!ZGVKS)2E5D?44J=+"4M]%
MNS1\!>%FU[5!=W,?^@VK`MD<2/V7^IKV<#`Q573=.M=*L(K*SB$<,0PH]?<^
MI-6A7HTJ:IQL?-XO$O$5.;IT"BBBM3D"BBB@`HHHH`*X?Q9X#-Y<'5]"?[+J
M"'>R*VT2'U![-^AKN**B4%)69K2JSI2YH,\TT;XDW6G3G3_$UK(LD9VM,J8=
M?]Y>_P!17?Z=JUAJT`FL+N*X3_8;)'U'454UWPSI?B&'9?6X,@'R3)PZ?0_T
M-><ZI\/->T.<W6CSO=(O(:%MDJ_AW_"L6ZE/S1VJ.&Q&SY)?@>NT5XS:?$/Q
M/I4GD7;K<%."EU%A_P`Q@UO6OQ=3`%YH[@]S#,"/R(IK$4WOH*>6XB.ROZ,]
M(HKB(_BMH3#]Y;7L9_ZY@_UIY^*GAT#A+T_]L1_C5^VI]S#ZGB/Y&=I17`3_
M`!;TU1_H^F74I[;V5/\`&L:]^*^JS`K9V-O;#LSDR'^@J7B*:ZFD,OQ,OLV/
M5R0`2>`.YKF=<\?Z)HP:-9_MER/^64!S@^[=!7D^I^)-:UC(OM1FD0_\LU.U
M/R'%98'10.3T`K">*?V4>A1RE+6K+[C?\1>,M5\1$QS2>1:YXMXCA3_O'^*L
M#@5T.C>!M>UDJR6AMH#_`,MKCY1CV'4UZ+X?^'FDZ,5GN!]NNEY#RK\JGV7_
M`!S64:52J[LZZF+PV%CR0^Y'#^%O`%]KK)<WH>SL>NXC#RC_`&1V'N:];T_3
MK32[*.SLH5AAC&`J_P`SZGWJR*6NZG2C36AX.)Q=3$/WMNP4"B@5J<@44M%`
M"44M%`"44M%`"44M%`"48I:*`*=_I.GZI'LOK.&X'_31`2/H>U<Q??"[0+DE
MK<W%FQ_YYR;E_)LUV=%1*$9;HVIUZM/X)-'F-Q\(I03]EUA2.PEAQ^H-53\)
M=6SQJ5F?P?\`PKUBBLWAZ;Z'4LRQ*^U^"/)_^%2ZM_T$;+\G_P`*F@^$5X3_
M`*1J\*C_`*9PD_S(KU*BE]6I]@>98E]?P1PMG\)]'A(-W=W5T1V!"#].?UKI
M=-\,Z-I.#9:=!$P_CV[F_,\UJT5K&G".R.:IB:U3XI-B8HI:*LP$HI:*`$HI
%:*`/_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
